These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9533060)

  • 21. Pharmacokinetic-pharmacodynamic modeling of the antihypertensive effect of eprosartan in Black and White hypertensive patients.
    van Rijn-Bikker PC; Ackaert O; Snelder N; van Hest RM; Ploeger BA; Koopmans RP; Mathôt RA
    Clin Pharmacokinet; 2013 Sep; 52(9):793-803. PubMed ID: 23696281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histamine H2-receptor antagonists have no clinically significant effect on the steady-state pharmacokinetics of voriconazole.
    Purkins L; Wood N; Kleinermans D; Nichols D
    Br J Clin Pharmacol; 2003 Dec; 56 Suppl 1(Suppl 1):51-5. PubMed ID: 14616414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of eprosartan, an angiotensin II AT1 receptor antagonist, on uric acid excretion in patients with mild to moderate essential hypertension.
    Ilson BE; Martin DE; Boike SC; Jorkasky DK
    J Clin Pharmacol; 1998 May; 38(5):437-41. PubMed ID: 9602957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of eprosartan in healthy subjects, patients with hypertension, and special populations.
    Bottorff MB; Tenero DM
    Pharmacotherapy; 1999 Apr; 19(4 Pt 2):73S-78S. PubMed ID: 10213525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stereoselective pharmacokinetics of chlorpheniramine and the effect of ranitidine.
    Koch KM; O'Connor-Semmes RL; Davis IM; Yin Y
    J Pharm Sci; 1998 Sep; 87(9):1097-100. PubMed ID: 9724561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. No effect of short term ranitidine intake on diclofenac pharmacokinetics.
    Leucuţa A; Vlase L; Farcau D; Nanulescu M
    Rom J Gastroenterol; 2004 Dec; 13(4):306-8. PubMed ID: 15624028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal hemodynamic response to an angiotensin II antagonist, eprosartan, in healthy men.
    Price DA; De'Oliveira JM; Fisher ND; Hollenberg NK
    Hypertension; 1997 Aug; 30(2 Pt 1):240-6. PubMed ID: 9260987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Central inhibition of AT1receptors by eprosartan--in vitro autoradiography in the brain.
    Muders F; Palkovits M; Bahner U; Kirst I; Elsner D; Jandeleit-Dahm K
    Pharmacol Res; 2001 Mar; 43(3):251-5. PubMed ID: 11401417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of enalapril and eprosartan on the renal vascular nitric oxide system in human essential hypertension.
    Delles C; Jacobi J; John S; Fleischmann I; Schmieder RE
    Kidney Int; 2002 Apr; 61(4):1462-8. PubMed ID: 11918753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative bioavailability of two tablet formulations of ranitidine hydrochloride in healthy volunteers.
    Bawazir SA; Gouda MW; El-Sayed YM; Al-Khamis KI; Al-Yamani MJ; Niazy EM; Al-Rashood KA
    Int J Clin Pharmacol Ther; 1998 May; 36(5):270-4. PubMed ID: 9629991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An interaction study with cimetidine and the new angiotensin II antagonist valsartan.
    Schmidt EK; Antonin KH; Flesch G; Racine-Poon A
    Eur J Clin Pharmacol; 1998 Feb; 53(6):451-8. PubMed ID: 9551704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic and safety profile of rupatadine when coadministered with azithromycin at steady-state levels: a randomized, open-label, two-way, crossover, Phase I study.
    Solans A; Izquierdo I; Donado E; Antonijoan R; Peña J; Nadal T; Carbó ML; Merlos M; Barbanoj M
    Clin Ther; 2008 Sep; 30(9):1639-50. PubMed ID: 18840369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of food, an antacid, and the H2 antagonist ranitidine on the absorption of BAY 59-7939 (rivaroxaban), an oral, direct factor Xa inhibitor, in healthy subjects.
    Kubitza D; Becka M; Zuehlsdorf M; Mueck W
    J Clin Pharmacol; 2006 May; 46(5):549-58. PubMed ID: 16638738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The renal profile of eprosartan.
    Sica DA; Hollenberg NK
    Pharmacotherapy; 1999 Apr; 19(4 Pt 2):86S-94S. PubMed ID: 10213527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics and bioequivalence study of irbesartan tablets after a single oral dose of 300 mg in healthy Thai volunteers.
    Wittayalertpanya S; Chariyavilaskul P; Prompila N; Sayankuldilok N; Eiamart W
    Int J Clin Pharmacol Ther; 2014 May; 52(5):431-6. PubMed ID: 24725445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of cimetidine and ranitidine on pharmacokinetics and pharmacodynamics of a single dose of dofetilide.
    Abel S; Nichols DJ; Brearley CJ; Eve MD
    Br J Clin Pharmacol; 2000 Jan; 49(1):64-71. PubMed ID: 10606839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Review of eprosartan: a new angiotensin II receptor antagonist. Summary.
    Sica DA
    Pharmacotherapy; 1999 Apr; 19(4 Pt 2):108S-109S. PubMed ID: 10213530
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
    Zhao RK; Cheng G; Tang J; Song J; Peng WX
    Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Concomitant Administration of a Histamine2 Receptor Antagonist and Proton Pump Inhibitor Enhances Gastric Acid Suppression.
    Abdul-Hussein M; Freeman J; Castell D
    Pharmacotherapy; 2015 Dec; 35(12):1124-9. PubMed ID: 26621819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.